HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Camastra, S. Articles by Ferrannini, E. Search for Related Content PubMed PubMed Citation Articles by Camastra, S. Articles by Ferrannini, E. Social Bookmarking                What's this?

ß-Cell Function in Morbidly Obese Subjects During Free Living

Long-Term Effects of Weight Loss

¹ Department of Internal Medicine, Metabolism Unit, National Research Council Institute of Clinical Physiology, University of Pisa, Pisa, Italy
² Department of Medicine, Catholic University, Rome, Italy
³ National Research Council Institute of Biomedical Engineering, Padua, Italy

Insulin hypersecretion and insulin resistance are physiologically linked features of obesity. We tested whether extreme hypersecretion impairs ß-cell function under free-living conditions and whether major weight loss modifies insulin hypersecretion, insulin sensitivity, and ß-cell function. Plasma glucose, C-peptide, and free fatty acid concentrations were measured at hourly intervals during 24 h of normal life (including calorie-standardized meals) in 20 morbidly obese nondiabetic patients (BMI 48.4 ± 1.7 kg/m²) and 7 nonobese age- and sex-matched control subjects; 8 of the obese patients were restudied 6 months and 2 years following biliopancreatic diversion. Insulin secretion was reconstructed from C-peptide levels by deconvolution and related to concurrent glucose levels through a mathematical model incorporating key features of ß-cell function: rate sensitivity, ß-cell glucose sensitivity, and potentiation. Insulin sensitivity (by the euglycemic insulin clamp technique) was reduced by 50% in obese subjects (23.1 ± 2.5 of obese subjects vs. 52.9 ± 4.9 µmol · min^–1 · kg_FFM^–1 of control subjects, means ± SE, P = 0.0004) as was mean 24-h insulin clearance (median 809 [interquartile range 451] vs. 1,553 [520] ml · min^–1 · m^–2, P < 0.001) due to a 50% reduction in hepatic insulin extraction (P < 0.01). Over 24 h, insulin secretion was doubled in obese subjects (468 nmol [202] in obese subjects vs. 235 [85] of control subjects, P = 0.0002). Despite the hypersecretion, ß-cell glucose sensitivity, rate sensitivity, and potentiation were similar in obese and control subjects. Six months postoperatively (weight loss = 33 ± 3 kg), both insulin hypersecretion (282 nmol [213]) and insulin sensitivity (51.6 ± 3.7 µmol · min^–1 · kg_FFM^–1) were normalized. At 2 years (weight loss = 50 ± 8 kg), insulin sensitivity was supernormal (68.7 ± 3.3 µmol · min^–1 · kg_FFM^–1) and insulin secretion was lower than normal (167 nmol [37]) (both P < 0.05 vs. control subjects). In conclusion, severe uncomplicated obesity is characterized by gross insulin hypersecretion and insulin resistance, but the dynamic aspects of ß-cell function are intact. Malabsorptive bariatric surgery corrects both the insulin hypersecretion and the insulin resistance at a time when BMI is still high. With continued weight loss over a 2-year period, moderately obese subjects become supersensitive to insulin and, correspondingly, insulin hyposecretors.

Abbreviations: FFA, free fatty acid; FFM, fat-free mass; TBW, total body water

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Cobelli, G. M. Toffolo, C. D. Man, M. Campioni, P. Denti, A. Caumo, P. Butler, and R. Rizza Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E1 - E15. [Abstract] [Full Text] [PDF]

				S. Camastra, M. Manco, A. Mari, A. V. Greco, S. Frascerra, G. Mingrone, and E. Ferrannini {beta}-Cell Function in Severely Obese Type 2 Diabetic Patients: Long-term effects of bariatric surgery Diabetes Care, April 1, 2007; 30(4): 1002 - 1004. [Full Text] [PDF]

				E. Lin, L. S. Phillips, T. R. Ziegler, B. Schmotzer, K. Wu, L. H. Gu, L. Khaitan, S. A. Lynch, W. E. Torres, C. D. Smith, et al. Increases in Adiponectin Predict Improved Liver, but Not Peripheral, Insulin Sensitivity in Severely Obese Women During Weight Loss Diabetes, March 1, 2007; 56(3): 735 - 742. [Abstract] [Full Text] [PDF]

				A. Lopez-Bermejo, B. Chico-Julia, M. Fernandez-Balsells, M. Recasens, E. Esteve, R. Casamitjana, W. Ricart, and J.-M. Fernandez-Real Serum Visfatin Increases With Progressive {beta}-Cell Deterioration. Diabetes, October 1, 2006; 55(10): 2871 - 2875. [Abstract] [Full Text] [PDF]

				J. J. Meier, A. E. Butler, R. Galasso, and P. C. Butler Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased {beta}-Cell Turnover Diabetes Care, July 1, 2006; 29(7): 1554 - 1559. [Abstract] [Full Text] [PDF]

				M. O. Larsen, B. Rolin, J. Sturis, M. Wilken, R. D. Carr, N. Porksen, and C. F. Gotfredsen Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Gottingen minipigs in vivo Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E670 - E677. [Abstract] [Full Text] [PDF]

				T. Carpenter, M. E. Trautmann, A. D. Baron, A. M. Kaiser, F. J. Service, G. B. Thompson, R. V. Lloyd, D. E. Cummings, M. H. Shannon, and M. J. Carlson Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery N. Engl. J. Med., November 17, 2005; 353(20): 2192 - 2194. [Full Text] [PDF]